Menopause [phsf]
Cardiovascular disease [dsyn]
Menopause [phsf]
Cardiovascular disease [dsyn]
Estrogen [horm, phsu, strd]
Withdrawal [acty]
Cardiovascular function [ortf]
Metabolism [orgf]
Menopause [phsf]
Compound [qlco]
Traditional [ftcn]
cardiovascular risk factor [dsyn]
Including [ftcn]
Body Fat Distribution [fndg]
Android [mnob]
Pattern [spco]
Reduced [qlco]
Glucose tolerance [phsf]
Abnormal [qlco]
Plasma lipids [lbpr]
BLOOD PRESSURE, INCREASED [dsyn]
Increased [qnco]
endothelial dysfunction [dsyn]
vascular inflammation [dsyn]
cardiovascular risk factor [dsyn]
IMPACT [gngm]
Men [popg]
Women [popg]
postmenopausal [tmco]
Women [popg]
treatment [ftcn]
arterial hypertension [dsyn]
Glucose Intolerance [dsyn]
Priorities [tmco]
Observational Study [resa]
Clinical Trials, Randomized [inpr, resa]
Suggest [idcn]
Hormone replacement therapy [topp]
Started [qlco]
Menopause [phsf]
CARDIOVASCULAR [bdsy]
Benefit [qnco]
Progestogens, Synthetic [horm, phsu, strd]
Continuous [idcn]
Combined [qlco]
HRT [topp]
Unique [qlco]
Progestagen [horm, phsu, strd]
drospirenone [orch, phsu]
properties [qlco]
drospirenone [orch, phsu]
Water [inch, phsu]
Sodium [bacs, elii]
retaining [ftcn]
effects [qlco]
Estrogen [horm, phsu, strd]
Component [mnob]
Hormone replacement therapy [topp]
Renin-Angiotensin-Aldosterone System [bdsy]
Weight Gain [fndg]
Raised blood pressure [fndg]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
17 beta-Estradiol [horm, phsu, strd]
drospirenone [orch, phsu]
Blood Pressure [orgf]
postmenopausal [tmco]
Women [popg]
Elevated blood pressure [fndg]
Normotensive [fndg]
Women [popg]
relieving [ftcn]
Climacteric [orgf]
symptoms [ftcn]
drospirenone [orch, phsu]
17 beta-Estradiol [horm, phsu, strd]
Benefit [qnco]
postmenopausal [tmco]
Women [popg]
Improved [qlco]
Cardiovascular disease [dsyn]
Profile [lbpr]
